M Shunsuke, O Fumihiko, T Ryusuke - Clinical Rheumatology, 2021 - search.proquest.com
Janus kinase (JAK) inhibitors have been developed as disease-modifying antirheumatic
drugs. Despite the positive therapeutic impacts of JAK inhibitors, concerns have been raised …